Ethinyl Estradiol/Norelgestromin

็‚”้›Œ้†‡/ๅŽป็”ฒ่‰พๅญ•ๆ˜Ž

Report date: 2026/04/09 20:00:21

Base Information

Drug NameEthinyl Estradiol/Norelgestromin
Drug Alias NameNorelgestromin+Ethinyl Estradiol็‚”้›Œ้†‡+ๅŽป็”ฒ่‰พๅญ•ๆ˜Ž็‚”้›Œ้†‡+็”ฒๅŸบๅญ•้…ฎEthinylestradiol/17-deacetyl norgestimate transdermal่ฏบๅญ•ๆ›ฒๆ˜Ž็‚”้›Œ้†‡ +[12]ย 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsEstrogen receptors agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsContraceptionMetrorrhagia
Global Approved IndicationsContraception
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2001/11/20
Country/TerritoryCanadaUnited StatesPuerto Rico +[5]ย 
CombinationsYes Ethinyl EstradiolNorelgestromin
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJohnson & Johnson Innovative MedicineJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesMylan IncLts Lohmann Therapie-Systeme AgMylan Technologies Inc +[5]ย 
Inactive CompaniesMcneil Consumer & Specialty Pharmaceuticals, A Division Of Mcneil-Ppc IncJanssen Pharmaceuticals IncJohnson & Johnson Pharmaceutical Research & Development LLC
Active IndicationsContraception
Inactive IndicationsMetrorrhagia

Other Information

ATC CodeG03AA13
Related LinksN/A